ACESION PHARMA ApS: Financial statements 2021
CVR: 34083738
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -25,157,000 compared with DKK -31,428,000 the year before. Equity in the 2021 report amounted to DKK 10,344,000. The solvency ratio was 30.5%.
- Revenue
- DKK 0
- Profit/Loss
- DKK -25,157,000
- Equity
- DKK 10,344,000
- Total Assets
- DKK 33,954,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | - | -25.2 mio. | 10.3 mio. | - |
| 2020 | 0 | - | -31.4 mio. | -20 mio. | - |
| 2019 | - | -35.8 mio. | -41.2 mio. | 524 t. | 7 |
| 2018 | - | -18.6 mio. | -25.1 mio. | -6.5 mio. | 10 |
| 2017 | - | -17.5 mio. | -24 mio. | -9.9 mio. | 12 |
Official annual report
Find more companies like ACESION PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
ACESION PHARMA ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -31,428,000.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 15 employees (2026). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.